Erlotinib overcomes paclitaxel-resistant cancer stem cells by blocking the EGFR-CREB/GRβ-IL-6 axis in MUC1-positive cervical cancer - Concepedia

Concepedia

Publication | Open Access

Erlotinib overcomes paclitaxel-resistant cancer stem cells by blocking the EGFR-CREB/GRβ-IL-6 axis in MUC1-positive cervical cancer

DOI Full Paper Access

42

Citations

43

References

2019

Year

Yaping Lv, Wei Cang, Quanfu Li, Xiaodong Liao, Mengna Zhan, Huayun Deng, Shengze Li, Wei Jin, Zhi Pang, Xingdi Qiu,

References

	Year	Citations

Page 1